1. Home
  2. XTLB vs ZAPP Comparison

XTLB vs ZAPP Comparison

Compare XTLB & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTLB
  • ZAPP
  • Stock Information
  • Founded
  • XTLB 1993
  • ZAPP 2017
  • Country
  • XTLB Israel
  • ZAPP Thailand
  • Employees
  • XTLB N/A
  • ZAPP N/A
  • Industry
  • XTLB Biotechnology: Pharmaceutical Preparations
  • ZAPP Motor Vehicles
  • Sector
  • XTLB Health Care
  • ZAPP Consumer Discretionary
  • Exchange
  • XTLB Nasdaq
  • ZAPP Nasdaq
  • Market Cap
  • XTLB 12.8M
  • ZAPP 13.5M
  • IPO Year
  • XTLB 2005
  • ZAPP N/A
  • Fundamental
  • Price
  • XTLB $2.19
  • ZAPP $2.66
  • Analyst Decision
  • XTLB
  • ZAPP
  • Analyst Count
  • XTLB 0
  • ZAPP 0
  • Target Price
  • XTLB N/A
  • ZAPP N/A
  • AVG Volume (30 Days)
  • XTLB 5.2K
  • ZAPP 117.6K
  • Earning Date
  • XTLB 11-20-2024
  • ZAPP 11-01-2024
  • Dividend Yield
  • XTLB N/A
  • ZAPP N/A
  • EPS Growth
  • XTLB N/A
  • ZAPP N/A
  • EPS
  • XTLB N/A
  • ZAPP N/A
  • Revenue
  • XTLB N/A
  • ZAPP N/A
  • Revenue This Year
  • XTLB N/A
  • ZAPP N/A
  • Revenue Next Year
  • XTLB N/A
  • ZAPP $41,300.00
  • P/E Ratio
  • XTLB N/A
  • ZAPP N/A
  • Revenue Growth
  • XTLB N/A
  • ZAPP N/A
  • 52 Week Low
  • XTLB $0.75
  • ZAPP $0.70
  • 52 Week High
  • XTLB $4.99
  • ZAPP $19.10
  • Technical
  • Relative Strength Index (RSI)
  • XTLB 42.07
  • ZAPP 35.60
  • Support Level
  • XTLB $2.13
  • ZAPP $2.56
  • Resistance Level
  • XTLB $2.56
  • ZAPP $2.85
  • Average True Range (ATR)
  • XTLB 0.11
  • ZAPP 0.18
  • MACD
  • XTLB -0.02
  • ZAPP 0.08
  • Stochastic Oscillator
  • XTLB 36.96
  • ZAPP 12.60

About XTLB XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.

Share on Social Networks: